Profile data is unavailable for this security.
About the company
Probiotec Limited is an Australia-based manufacturer, packer and distributor of a range of prescription and over the counter (OTC) pharmaceuticals, complementary medicines, consumer health products, and fast-moving consumer goods (FMCG). The Company owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. It offers full-service contract manufacturing and packing. The Company manufactures products on behalf of a range of clients, including international pharmaceutical companies. The Company services blue-chip manufacturers, multinational FMCG companies, local manufacturers and brand custodians. All types of FMCG products are packed or handled, such as canned food, alcohol, tea and coffee, dairy and frozen foods, sauces and condiments, and bottled water. Its subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Multipack-LJM Pty Ltd, LJM (NSW) Pty Ltd and HH Packaging Pty Ltd.
- Revenue in AUD (TTM)221.22m
- Net income in AUD8.69m
- Incorporated1996
- Employees111.00
- LocationProbiotec Ltd83 Cherry Lane, Laverton NorthMELBOURNE 3026AustraliaAUS
- Phone+61 39369-6730
- Fax+61 39369-6730
- Websitehttp://www.probiotec.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vita Life Sciences Limited | 74.16m | 9.08m | 127.10m | 124.00 | 13.73 | 2.96 | 13.25 | 1.71 | 0.166 | 0.166 | 1.36 | 0.7695 | 1.33 | 2.34 | 7.35 | -- | 16.27 | 15.25 | 22.51 | 21.99 | 58.14 | 60.90 | 12.24 | 11.71 | 2.29 | -- | 0.0089 | 39.05 | 10.88 | 12.50 | 28.18 | 30.07 | 12.15 | 19.14 |
| Proteomics International LaboratoriesLtd | 1.44m | -5.90m | 128.27m | -- | -- | 22.40 | -- | 88.78 | -0.0518 | -0.0518 | 0.0129 | 0.0437 | 0.1817 | -- | 11.13 | -- | -75.75 | -57.79 | -87.11 | -67.57 | -- | -- | -416.78 | -229.69 | -- | -283.47 | 0.0088 | -- | -14.64 | 4.12 | -24.20 | -- | 89.02 | -- |
| Cogstate Ltd | 62.43m | 8.29m | 210.85m | 61.00 | 27.72 | 3.69 | 16.97 | 3.38 | 0.0444 | 0.0444 | 0.3382 | 0.333 | 0.7757 | -- | 5.58 | -- | 10.30 | 6.01 | 13.84 | 9.22 | 54.69 | 51.50 | 13.28 | 7.26 | -- | -- | 0.0135 | 0.00 | -8.62 | 7.25 | -52.56 | -- | -5.06 | -- |
| Dimerix Ltd | 181.28k | -10.87m | 214.37m | 0.00 | -- | 96.81 | -- | 1,182.55 | -0.0294 | -0.0294 | 0.0005 | 0.004 | 0.0169 | -- | 0.7586 | -- | -101.36 | -70.77 | -128.88 | -110.81 | -- | -- | -5,994.52 | -61,882.73 | -- | -- | 0.4541 | -- | 1,452.32 | 12.76 | -31.57 | -- | -8.26 | -- |
| Race Oncology Ltd | 885.59k | -11.17m | 236.24m | -- | -- | 11.24 | -- | 266.77 | -0.069 | -0.069 | 0.0055 | 0.125 | 0.0336 | -- | 0.326 | -- | -42.44 | -43.50 | -43.67 | -45.25 | -- | -- | -1,261.86 | -5,058.82 | -- | -- | 0.00 | -- | 997.63 | 93.78 | 11.41 | -- | -- | -- |
| Probiotec Ltd | 221.22m | 8.69m | 242.34m | 111.00 | 28.70 | 2.74 | 10.12 | 1.10 | 0.1038 | 0.1038 | 2.64 | 1.09 | 0.9483 | 7.03 | 6.99 | -- | 3.72 | 4.58 | 5.36 | 5.94 | 29.95 | 30.21 | 3.93 | 5.73 | 1.09 | 3.33 | 0.4937 | 47.90 | 17.39 | 23.10 | -19.61 | 20.84 | 12.97 | 18.77 |
| Holder | Shares | % Held |
|---|---|---|
| Paradice Investment Management Pty Ltd.as of 20 Sep 2023 | 5.80m | 7.13% |
| Perpetual Investment Management Ltd.as of 10 Oct 2023 | 4.97m | 6.11% |
| Copia Investment Partners Ltd.as of 29 Sep 2022 | 4.46m | 5.48% |
| Harvest Lane Asset Management Pty Ltd.as of 15 Mar 2024 | 4.16m | 5.12% |
| Pie Funds Management Ltd.as of 23 Jan 2023 | 4.13m | 5.08% |
| Investors Mutual Ltd.as of 30 Apr 2024 | 960.00k | 1.18% |
| DFA Australia Ltd.as of 30 Apr 2024 | 621.53k | 0.76% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 121.23k | 0.15% |
| Acadian Asset Management LLCas of 31 Mar 2024 | 25.96k | 0.03% |
| Dimensional Fund Advisors Ltd.as of 09 May 2024 | 9.38k | 0.01% |
